News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,447 Results
Type
Article (13985)
Company Profile (103)
Press Release (255358)
Multimedia
Podcasts (53)
Webinars (13)
Section
Business (88330)
Career Advice (465)
Deals (15428)
Drug Delivery (67)
Drug Development (36708)
Employer Resources (49)
FDA (6341)
Job Trends (6231)
News (150761)
Policy (14101)
Tag
Academia (445)
Accelerated approval (4)
Adcomms (6)
Allergies (44)
Alliances (23353)
ALS (44)
Alzheimer's disease (434)
Antibody-drug conjugate (ADC) (56)
Approvals (6406)
Artificial intelligence (137)
Autoimmune disease (10)
Automation (6)
Bankruptcy (150)
Best Places to Work (4377)
BIOSECURE Act (9)
Biosimilars (71)
Biotechnology (41)
Bladder cancer (24)
Brain cancer (20)
Breast cancer (110)
Cancer (854)
Cardiovascular disease (90)
Career advice (409)
Career pathing (12)
CAR-T (31)
CDC (3)
Cell therapy (106)
Cervical cancer (6)
Clinical research (31346)
Collaboration (457)
Compensation (209)
Complete response letters (19)
COVID-19 (773)
CRISPR (28)
C-suite (200)
Cystic fibrosis (46)
Data (970)
Denatured (16)
Depression (18)
Diabetes (97)
Diagnostics (1341)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (72)
Drug pricing (82)
Drug shortages (12)
Duchenne muscular dystrophy (56)
Earnings (32738)
Editorial (14)
Employer branding (4)
Employer resources (44)
Events (38174)
Executive appointments (472)
FDA (6991)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (291)
Gene editing (46)
Generative AI (9)
Gene therapy (119)
GLP-1 (383)
Government (1338)
Grass and pollen (4)
Guidances (97)
Healthcare (3588)
HIV (7)
Huntington's disease (5)
IgA nephropathy (19)
Immunology and inflammation (48)
Immuno-oncology (2)
Indications (21)
Infectious disease (814)
Inflammatory bowel disease (60)
Inflation Reduction Act (7)
Influenza (15)
Intellectual property (67)
Interviews (59)
IPO (5924)
IRA (32)
Job creations (2068)
Job search strategy (373)
Kidney cancer (7)
Labor market (19)
Layoffs (191)
Leadership (4)
Legal (3451)
Liver cancer (20)
Longevity (6)
Lung cancer (117)
Lymphoma (73)
Machine learning (4)
Management (16)
Manufacturing (226)
MASH (46)
Medical device (1372)
Medtech (1374)
Mergers & acquisitions (9787)
Metabolic disorders (318)
Multiple sclerosis (29)
NASH (14)
Neurodegenerative disease (35)
Neuropsychiatric disorders (12)
Neuroscience (670)
NextGen: Class of 2025 (1594)
Non-profit (603)
Now hiring (12)
Obesity (175)
Opinion (130)
Ovarian cancer (27)
Pain (72)
Pancreatic cancer (29)
Parkinson's disease (52)
Partnered (7)
Patents (156)
Patient recruitment (50)
Peanut (12)
People (29285)
Pharmaceutical (64)
Pharmacy benefit managers (14)
Phase I (8158)
Phase II (13258)
Phase III (11908)
Pipeline (710)
Policy (99)
Postmarket research (1401)
Preclinical (3278)
Press Release (25)
Prostate cancer (64)
Psychedelics (10)
Radiopharmaceuticals (126)
Rare diseases (214)
Real estate (2650)
Recruiting (17)
Regulatory (10345)
Reports (14)
Research institute (570)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (5)
RSV (10)
Schizophrenia (45)
Series A (56)
Series B (23)
Service/supplier (3)
Sickle cell disease (36)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (7)
Startups (1642)
State (2)
Stomach cancer (3)
Supply chain (36)
Tariffs (47)
The Weekly (35)
Vaccines (183)
Venture capital (20)
Weight loss (104)
Women's health (10)
Worklife (4)
Date
Today (7)
Last 7 days (187)
Last 30 days (641)
Last 365 days (11051)
2025 (6539)
2024 (12534)
2023 (14292)
2022 (19617)
2021 (20130)
2020 (19096)
2019 (14923)
2018 (11756)
2017 (13934)
2016 (13159)
2015 (15499)
2014 (12447)
2013 (10614)
2012 (11424)
2011 (11965)
2010 (10939)
Location
Africa (317)
Alabama (16)
Alaska (1)
Arizona (61)
Arkansas (3)
Asia (20413)
Australia (2640)
California (2227)
Canada (1120)
China (349)
Colorado (88)
Connecticut (91)
Delaware (80)
Europe (40042)
Florida (435)
Georgia (48)
Hawaii (1)
Idaho (9)
Illinois (256)
India (18)
Indiana (168)
Iowa (1)
Japan (146)
Kansas (64)
Kentucky (17)
Louisiana (2)
Maine (2)
Maryland (321)
Massachusetts (1936)
Michigan (37)
Minnesota (120)
Mississippi (1)
Missouri (24)
Montana (8)
Nebraska (6)
Nevada (13)
New Hampshire (8)
New Jersey (998)
New Mexico (7)
New York (661)
North Carolina (469)
North Dakota (2)
Northern California (930)
Ohio (57)
Oklahoma (4)
Oregon (16)
Pennsylvania (544)
Puerto Rico (9)
Rhode Island (11)
South America (504)
South Carolina (5)
Southern California (942)
Tennessee (43)
Texas (310)
United States (9248)
Utah (45)
Virginia (111)
Washington D.C. (38)
Washington State (150)
West Virginia (1)
Wisconsin (23)
269,447 Results for "kala pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
KALA BIO to Present at Jefferies Global Healthcare Conference
May 29, 2025
·
1 min read
Press Releases
KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
July 10, 2025
·
5 min read
Press Releases
KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
July 8, 2025
·
2 min read
Press Releases
KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 15, 2025
·
10 min read
Press Releases
KALA BIO Announces Chief Executive Officer Transition
February 13, 2025
·
5 min read
Press Releases
KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
April 1, 2025
·
13 min read
Press Releases
KALA BIO to Present at TD Cowen 45th Annual Health Care Conference
February 26, 2025
·
1 min read
BioCapital
KALA BIO to Present at Jefferies 2024 Global Healthcare Conference
KALA BIO, Inc. announced that Kim Brazzell, Ph.D., Head of R&D and Chief Medical Officer of KALA BIO, will present at the Jefferies Global Healthcare Conference being held in New York, NY on Wednesday, June 5, 2024 at 12:30 p.m. ET.
May 29, 2024
·
1 min read
Genetown
Kala Pharmaceuticals Announces Name Change to KALA BIO
Kala Pharmaceuticals, Inc. today announced that it will change its name to KALA BIO, Inc. effective August 2, 2023, to better reflect the company’s focus on advancing biologics for the treatment of ophthalmic conditions.
August 2, 2023
·
5 min read
Press Releases
KALA BIO Announces $10,750,000 Private Placement
December 30, 2024
·
5 min read
1 of 26,945
Next
